v3.26.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flow from operating activities    
Net loss $ (7,426,566) $ (10,069,264)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 854,079 989,326
Share-based, compensation, net 2,221,922 3,142,089
Interest expense/(income), net 112,630 (198,377)
Foreign exchange gains (251,213) (451,270)
Provision for inventory obsolescence 3,242 3,683
Other non-cash 261,356 (299,650)
Changes in operating assets and liabilities:    
Accounts receivable (119,937) (291,566)
Inventories 64,173 (30,983)
Other current assets 111,373 1,117,313
Accounts payable (2,118,443) 289,165
Deferred revenue 231,366 (59,829)
Accrued expenses and other current liabilities 400,982 298,876
A. Net cash used in operating activities (5,655,036) (5,560,487)
Cash flow from investing activities    
Purchase of property and equipment (131,280) (174,065)
B. Net cash used in investing activities (131,280) (174,065)
Cash flow from financing activities    
Proceeds from issuance of convertible notes 2,745,488 4,375,750
Repayment of term loans (416,666)
Proceeds from exercise of employee share options 166,261
C. Net cash generated from financing activities 2,745,488 4,125,345
D. Decrease in cash and cash equivalents (A+B+C) (3,040,828) (1,609,207)
E. Cash and cash equivalents at beginning of the period 7,805,859 5,148,857
Cash and cash equivalents at ending of the period (D+E) 4,765,031 3,539,650
Supplemental disclosures of cash flow information:    
Interest paid, net $ (4,030,836) $ (3,112,342)